ALTEROLA BIOTECH INC.
company.status.inactiveCIK 1442999fmd_0CHQJNNKNBB9A1BXFT4BJFJTCTManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jul 21, 2008 to Sep 30, 2024, 60 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Cost of revenue | – | – | – | – | – | – | – | – | – | – |
| Gross profit | – | – | – | – | – | – | – | – | – | – |
| Research and development | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Total operating expenses | 0 | 0 | 0 | 0 | 0 | – | 0 | 6 | 2 | 2 |
| Operating income | (0) | (0) | (0) | (0) | (0) | – | (0) | (6) | (2) | (2) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Other non-operating income (expense) | (0) | (0) | (0) | (0) | (0) | 0 | – | – | (0) | (0) |
| Income tax expense | – | – | 0 | 0 | 0 | 0 | – | – | – | – |
| Net income | (0) | (0) | (0) | (0) | (0) | – | (0) | (6) | (2) | (2) |
| Net income to common shareholders | (0) | (0) | (0) | (0) | (0) | (0) | – | – | – | – |